CombiMatrix, a CLIA-certified laboratory, is bringing microarray analysis to the underserved problem of recurrent pregnancy loss as well as to prenatal testing. CombiMatrix performs microarray ...

Unclear Results After Microarray Testing Many studies have demonstrated the increased detection rate of chromosome abnormalities after microarray testing. With each of these, the clinically ...

Chromosomal microarray analysis, which compares specific regions of an unborn baby’s DNA to that of a normal genome, should be offered to all expectant mothers, say researchers at Columbia ...

Microarray testing is used in pediatric patients with developmental delay, intellectual disability, multiple congenital anomalies, and autism spectrum disorders. 12,13 Although in some cases ...

All India Institute of Medical Sciences (AIIMS) Jammu has launched Maternal and Fetal Medicine (MFM) services, bringing ...

AliveDx, the global in-vitro diagnostics company that aims to transform patient care, today announces that it has submitted 510(k) premarket notification to the U.S. Food and Drug Administration (FDA) ...

PathogenDx's breakthrough technology shifts the pathogen detection paradigm from microbial to molecular testing through its microarray assays, namely DetectX, EnviroX, and QuantX SANTA CLARA ...

PathogenDx has introduced QuantX Bacterial, a novel four-in-one assay streamlining microbial testing compliance for cannabis laboratories across states. Headquartered in Scottsdale, Arizona ...

Benefits of genetic testing in adults with unexplained epilepsy include enrollment in a clinical trial of a relevant gene therapy, connection to families with a similar diagnosis, and peace of mind.